Gelteq Limited Ordinary Shares Market Cap ($5.24 Million)
Market Cap & Net Worth: Gelteq Limited Ordinary Shares (GELS)
Gelteq Limited Ordinary Shares market cap. Gelteq Limited Ordinary Shares (NASDAQ:GELS) has a market capitalization of $5.24 Million ($5.24 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28417 globally and #5851 in its home market, demonstrating a 9.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gelteq Limited Ordinary Shares's stock price $0.49 by its total outstanding shares 10711059 (10.71 Million). Also see GELS cash flow metrics for how efficiently the company converts equity into cash flow.
Gelteq Limited Ordinary Shares Market Cap History (2024–2026)
Gelteq Limited Ordinary Shares market cap history from 2024 to 2026. Data shows change from $24.85 Million to $5.24 Million (-58.97% CAGR). Check Gelteq Limited Ordinary Shares (GELS) share price today for real-time trading data and today's change.
Index Memberships
Gelteq Limited Ordinary Shares is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #811 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2608 of 3165 |
Weight: Gelteq Limited Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Gelteq Limited Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gelteq Limited Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GELS year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
51.73x
Gelteq Limited Ordinary Shares's market cap is 51.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $8.57 Million | $165.65K | -$6.65 Million | 51.73x | N/A |
Competitor Companies of GELS by Market Capitalization
Companies near Gelteq Limited Ordinary Shares in the global market cap rankings as of November 4, 2026. Also see Gelteq Limited Ordinary Shares asset portfolio for a full breakdown of the balance sheet.
Key companies related to Gelteq Limited Ordinary Shares by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Gelteq Limited Ordinary Shares (2024–2026)
Market capitalization of Gelteq Limited Ordinary Shares from 2024 to today. Between 2024 and today, Gelteq Limited Ordinary Shares's market cap moved from $24.85 Million to $ 5.24 Million, with a yearly change of -58.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.24 Million | -38.88% |
| 2025 | $8.57 Million | -65.52% |
| 2024 | $24.85 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Gelteq Limited Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.24 Million USD |
| MoneyControl | $5.24 Million USD |
| MarketWatch | $5.24 Million USD |
| marketcap.company | $5.24 Million USD |
| Reuters | $5.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Austra… Read more